MicroRNA-92b Promotes Hepatocellular Carcinoma Progression by Targeting Smad7 and is Mediated by Long Non-coding RNA XIST

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2016 Apr 22

PMID 27100897

Citations 105

Authors

L K Zhuang

Y T Yang

X Ma

B Han

Z S Wang

Q Y Zhao

L Q Wu

Z Q Qu

Affiliations

Soon will be listed here.

Abstract

MicroRNA (miRNA) and long non-coding RNA (lncRNA) have been demonstrated to participate in the progression of many cancers. Hepatocellular carcinoma (HCC) is one of the most common and aggressive malignant tumors worldwide, while the molecular mechanisms underlying HCC tumorigenesis are not completely clear. In this study, we showed that miR-92b was significantly upregulated in tumor tissue and plasma of HCC patients, and its expression level was highly correlated with gender and microvascular invasion. Functionally, miR-92b could promote cell proliferation and metastasis of HCC in vitro and in vivo. Mechanistic investigations suggested that Smad7, which exhibited an inverse relationship with miR-92b expression in HCC, was a direct target of miR-92b and could reverse its effects on HCC tumorigenesis. Furthermore, long non-coding RNA (lncRNA) X-inactive specific transcript (XIST) and miR-92b could directly interact with and repress each other, and XIST could inhibit HCC cell proliferation and metastasis by targeting miR-92b. Taken together, our study not only revealed for the first time the importance of XIST/miR-92b/Smad7 signaling axis in HCC progression but also suggested the potential value of miR-92b as a biomarker in the clinical diagnosis and treatment of HCC.

Citing Articles

X-inactive-specific transcript: a long noncoding RNA with a complex role in sex differences in human disease.

Predescu D, Mokhlesi B, Predescu S Biol Sex Differ. 2024; 15(1):101.

PMID: 39639337 PMC: 11619133. DOI: 10.1186/s13293-024-00681-5.

Inflammation-Associated Long Non-Coding RNAs (lncRNAs) in Chronic Viral Hepatitis- Associated Hepatocellular Carcinoma.

Pehlivanoglu B, Aysal A, Agalar C, Egeli T, Ozbilgin M, Unek T Turk Patoloji Derg. 2024; 41(1):1-8.

PMID: 39397388 PMC: 11826398. DOI: 10.5146/tjpath.2024.13593.

MicroRNA as Key Players in Hepatocellular Carcinoma: Insights into Their Role in Metastasis.

Saadh M, Hussain Q, Alazzawi T, Fahdil A, Athab Z, Yarmukhamedov B Biochem Genet. 2024; .

PMID: 39103713 DOI: 10.1007/s10528-024-10897-0.

Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma.

Ucdal M, Burus A, Celtikci B Hepatol Forum. 2024; 5(3):150-160.

PMID: 39006147 PMC: 11237245. DOI: 10.14744/hf.2023.2023.0028.

Involvement of lncRNAs in the regulation of aerobic glycolysis in hepatocellular carcinoma: Main functions, regulatory mechanisms and potential therapeutic implications (Review).

Huang Q, Liang Z, Huang Q, Li X, Xia J, Huang L Oncol Rep. 2024; 51(6).

PMID: 38666534 PMC: 11082637. DOI: 10.3892/or.2024.8743.

References

Krol J, Loedige I, Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11(9):597-610. DOI: 10.1038/nrg2843. View

Cho W . MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol. 2009; 42(8):1273-81. DOI: 10.1016/j.biocel.2009.12.014. View

Villanueva A, Hoshida Y, Toffanin S, Lachenmayer A, Alsinet C, Savic R . New strategies in hepatocellular carcinoma: genomic prognostic markers. Clin Cancer Res. 2010; 16(19):4688-94. PMC: 3395071. DOI: 10.1158/1078-0432.CCR-09-1811. View

Kawakami T, Okamoto K, Sugihara H, Hattori T, Reeve A, Ogawa O . The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors. J Urol. 2003; 169(4):1546-52. DOI: 10.1097/01.ju.0000044927.23323.5a. View

Patel M, Verma A, Aslam I, Pringle H, Singh B . Novel plasma microRNA biomarkers for the identification of colitis-associated carcinoma. Lancet. 2015; 385 Suppl 1:S78. DOI: 10.1016/S0140-6736(15)60393-2. View

Gao Y, Meng H, Liu S, Hu J, Zhang Y, Jiao T . LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b. Hum Mol Genet. 2014; 24(3):841-52. DOI: 10.1093/hmg/ddu502. View

Giordano S, Columbano A . MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?. Hepatology. 2012; 57(2):840-7. DOI: 10.1002/hep.26095. View

Zhuang L, Xu G, Pan X, Lou Y, Zou Q, Xia D . MicroRNA-181a-mediated downregulation of AC9 protein decreases intracellular cAMP level and inhibits ATRA-induced APL cell differentiation. Cell Death Dis. 2014; 5:e1161. PMC: 5424108. DOI: 10.1038/cddis.2014.130. View

Huang J, Zheng L, Hu Y, Wang Q . Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. Carcinogenesis. 2013; 35(3):507-14. DOI: 10.1093/carcin/bgt405. View

10.

Wang K, Wang X, Zou J, Zhang A, Wan Y, Pu P . miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase. Neuro Oncol. 2013; 15(5):578-88. PMC: 3635522. DOI: 10.1093/neuonc/not004. View

11.

Liu W, Ling S, Sun W, Liu T, Li Y, Zhong G . Circulating microRNAs correlated with the level of coronary artery calcification in symptomatic patients. Sci Rep. 2015; 5:16099. PMC: 4633594. DOI: 10.1038/srep16099. View

12.

Kan H, Guo W, Huang Y, Liu D . MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7. FEBS Lett. 2014; 589(1):102-9. DOI: 10.1016/j.febslet.2014.11.031. View

13.

Guy J, Peters M . Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes. Gastroenterol Hepatol (N Y). 2014; 9(10):633-9. PMC: 3992057. View

14.

Lo H, Wu S, Huang H, Yeh C, Huang J, Hsieh C . Laparoscopic simple closure alone is adequate for low risk patients with perforated peptic ulcer. World J Surg. 2011; 35(8):1873-8. DOI: 10.1007/s00268-011-1106-7. View

15.

Khoury S, Tran N . Circulating microRNAs: potential biomarkers for common malignancies. Biomark Med. 2015; 9(2):131-51. DOI: 10.2217/bmm.14.102. View

16.

Ruggieri A, Barbati C, Malorni W . Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity. Int J Cancer. 2010; 127(3):499-504. DOI: 10.1002/ijc.25298. View

17.

Yao Y, Ma J, Xue Y, Wang P, Li Z, Liu J . Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Cancer Lett. 2015; 359(1):75-86. DOI: 10.1016/j.canlet.2014.12.051. View

18.

Lu F, Sun Y, Wei C, Thisse C, Thisse B . Tissue-specific derepression of TCF/LEF controls the activity of the Wnt/β-catenin pathway. Nat Commun. 2014; 5:5368. DOI: 10.1038/ncomms6368. View

19.

Wu Z, Cai L, Lin S, Lu J, Yao Y, Zhou L . The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas. Brain Res. 2013; 1529:16-25. DOI: 10.1016/j.brainres.2013.07.031. View

20.

Millar S . Smad7: licensed to kill beta-catenin. Dev Cell. 2006; 11(3):274-6. DOI: 10.1016/j.devcel.2006.08.008. View